Inobrodib exhibits encouraging preclinical and early-phase clinical activity through disrupting the action of p300/CBP at regulatory elements controlling key cancer genes.Inobrodib is the first in a new class of drug with promise in relapsed refractory multiple myeloma and other haematological malignancies.Patients.
'I put night sweats down to the menopause - then I was told I had months to live' manchestereveningnews.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from manchestereveningnews.co.uk Daily Mail and Mail on Sunday newspapers.